Effects of CCR5 Genetic Polymorphism and HIV-1 Subtype in Antiretroviral Response in Brazilian HIV-1–Infected Patients
- 1 August 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (4) , 399
- https://doi.org/10.1097/00042560-200008010-00016
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Association of the CCR5Delta32 Mutation With Improved Response to Antiretroviral TherapyPublished by American Medical Association (AMA) ,1999
- Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease ProgressionThe Journal of Infectious Diseases, 1999
- Virological and Immunological Features of Long-Term Human Immunodeficiency Virus–Infected Individuals Who Have Remained Asymptomatic Compared With Those Who Have Progressed to Acquired Immunodeficiency SyndromeBlood, 1998
- Human Immunodeficiency Virus Type 1 Subtype F Reverse Transcriptase Sequence and Drug SusceptibilityJournal of Virology, 1998
- Association between CCR5 Genotype and the Clinical Course of HIV-1 InfectionAnnals of Internal Medicine, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progressionNature Medicine, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIVScience, 1996
- Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genesScience, 1993